19265486

Source:http://linkedlifedata.com/resource/pubmed/id/19265486

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0018823, umls-concept:C0021079, umls-concept:C1527148
pubmed:issue	1
pubmed:dateCreated	2009-3-12
pubmed:abstractText	Heart transplantation is a well-established therapeutic option for many patients with end-stage heart disease. A major challenge in heart transplantation today is providing effective immunosuppression to prevent graft rejection while minimizing the many adverse effects of currently available therapies.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/101135662
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Immunosuppressive Agents
pubmed:status	MEDLINE
pubmed:month	Mar
pubmed:issn	1744-7623
pubmed:author	pubmed-author:KhushKiran KKK, pubmed-author:ValantineHannah AHA
pubmed:issnType	Electronic
pubmed:volume	14
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	1-21
pubmed:meshHeading	pubmed-meshheading:19265486-Animals, pubmed-meshheading:19265486-Clinical Trials as Topic, pubmed-meshheading:19265486-Drug Delivery Systems, pubmed-meshheading:19265486-Drug Design, pubmed-meshheading:19265486-Graft Rejection, pubmed-meshheading:19265486-Heart Diseases, pubmed-meshheading:19265486-Heart Transplantation, pubmed-meshheading:19265486-Humans, pubmed-meshheading:19265486-Immunosuppressive Agents
pubmed:year	2009
pubmed:articleTitle	New developments in immunosuppressive therapy for heart transplantation.
pubmed:affiliation	Stanford University School of Medicine, Division of Cardiovascular Medicine, Stanford, CA 94305, USA. kkhush@cvmed.stanford.edu
pubmed:publicationType	Journal Article, Review